To verify our results, we employed various methods, including counting cell numbers, CCK-8 assay, Ki-67 immunostaining, colony formation, and cyclin D1, and these experiments all yielded consistently supportive evidence that SLFN5 plays inhibitory roles in lung cancer cell proliferation. Here, SLFN5 is linked to lung cancer.